Epix joins Nasdaq biotech index

MR contrast developer Epix Medical will be joining the Nasdaq’s Biotechnology Index (NBI).

The listing is effective prior to market opening on Monday, November 24, according to the Cambridge, MA-based vendor.

By AuntMinnie.com staff writers
November 14, 2003

Related Reading

Epix COO resigns, November 11, 2003

Epix continues to build revenues, trim losses in Q3, October 24, 2003

Epix to present phase III results, September 15, 2003

Epix exercises overallotment option, August 27, 2003

Epix sets share price, August 7, 2003

Copyright © 2003 AuntMinnie.com

Page 1 of 610
Next Page